Alphavirus replicon particle vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: Proof of concept

Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, 11 Kildee, Ames, IA 50011, USA.
Vaccine (Impact Factor: 3.62). 10/2009; 28(3):594-6. DOI: 10.1016/j.vaccine.2009.10.015
Source: PubMed


A propagation-defective, single-cycle, alphavirus replicon particle (RP) system was used to produce two vaccines against human influenza virus A/Wyoming/0312003 (H3N2). One vaccine was prepared from Venezeulan equine encephalitis virus (VEEV) strain 3014 and the other from VEEV strain TC-83. Both vaccines induced high antibody titers to the influenza hemagglutinin (HA) protein and illustrated the potential of using alphavirus RP influenza vaccines in swine. (C) 2009 Elsevier Ltd. All rights reserved

Download full-text


Available from: Kurt I Kamrud, Mar 18, 2014
Show more